Noble metal-containing compound detection by catalysis of optical dye reduction
US-2024377333-A1 · Nov 14, 2024 · US
US2018180536A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2018180536-A1 |
| Application number | US-201815891632-A |
| Country | US |
| Kind code | A1 |
| Filing date | Feb 8, 2018 |
| Priority date | Aug 12, 2014 |
| Publication date | Jun 28, 2018 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A sample test method, microfluidic device, and test device efficiently and accurately compensates for interference of an interfering substance present in a sample using optical measurement without addition of a separate reagent for detecting the interfering substance. The sample test method includes: measuring an optical characteristic value of a target substance present in a sample; measuring an optical characteristic value of an interfering substance present in the sample; and determining a concentration of the target substance for which interference of the interfering substance is compensated for based on the optical characteristic value of the interfering substance.
Opening claim text (preview).
What is claimed is: 1 . A sample test method comprising: measuring an optical characteristic value of a target substance present in a sample; measuring an optical characteristic value of an interfering substance present in the sample; and determining a concentration of the target substance for which interference of the interfering substance is compensated for based on the optical characteristic value of the interfering substance, wherein the determining the concentration of the target substance for which interference of the interfering substance is compensated for comprises: determining the concentration of the target substance based on the optical characteristic value of the target substance, and determining the concentration of the interfering substance based on the optical characteristic value of the interfering substance, and compensating the concentration of the target substance using the concentration of the interfering substance. 2 . The sample test method of claim 1 , wherein the compensating the optical characteristic value of the target substance comprises: applying a fluctuation coefficient to the concentration of the interfering substance to obtain an application result, and then subtracting or adding the application result from or to the concentration of the target substance. 3 . The sample test method of claim 1 , wherein the measuring the optical characteristic value of the target substance comprises: measuring optical characteristic values of the target substance at a main wavelength and a sub-wavelength; and subtracting the optical characteristic value at the sub-wavelength from the optical characteristic value at the main wavelength. 4 . The sample test method of claim 1 , wherein the sample includes blood, and wherein the target substance includes gamma-glutamyl transferase (GGT). 5 . The sample test method of claim 1 , wherein the interfering substance includes bilirubin. 6 . The sample test method of claim 1 , wherein the measuring the optical characteristic value of the interfering substance is done without presence of a reagent for reacting with the interfering substance. 7 . The sample test method according to claim 1 , wherein the optical characteristic value is representative of concentration amount of at least one of the target substance and the interfering substance, and the sample test method is performed using one or more processors. 8 . A test device comprising: a measurer configured to measure an optical characteristic value of a target substance present in a sample and an optical characteristic value of an interfering substance present in the sample; and a data processor configured to determine a concentration of the target substance for which interference of the interfering substance is compensated for based on the optical characteristic value of the interfering substance, wherein the data processor is configured to determine the concentration of the target substance based on the optical characteristic value of the target substance, and determine the concentration of the interfering substance based on the optical characteristic value of the interfering substance, and compensate the concentration of the target substance using the concentration of the interfering substance. 9 . The test device of claim 8 , wherein the data processor is configured to apply a fluctuation coefficient to the concentration of the interfering substance to obtain an application result, and then subtract or add the application result from or to the concentration of the target substance. 10 . The test device of claim 8 , wherein the measurer is configured to the measure optical characteristic value of the target substance at a main wavelength and a sub-wavelength, and wherein the data processor is configured to subtract the optical characteristic value measured at the sub-wavelength from the optical characteristic value measured at the main wavelength. 11 . The test device of claim 8 , wherein the sample includes blood, and wherein the target substance includes gamma-glutamyl transferase (GGT). 12 . The test device of claim 8 , wherein the measurer is configured to the measure optical characteristic value of the sample at a plurality of wavelengths, and wherein the data processor is configured to determine a final optical characteristic value from the measured optical characteristic values of the sample, wherein the final optical characteristic value is an optical characteristic value for the interfering substance. 13 . The test device of claim 11 , wherein the interfering substance includes bilirubin.
Flow-through cuvettes (G01N21/09 takes precedence; handling fluid samples G01N1/10) · CPC title
with definite EC number (2.3.2.-) · CPC title
Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry {(G01N21/72 takes precedence)} · CPC title
Determining multicomponents by multiwavelength light · CPC title
Bile pigment · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.